DuoGenic StemCells (7607.TWO) Stock Price

DuoGenic StemCells Price

CLOSED
8.43
​
Market closed

Over the last 3 years DuoGenic StemCells grew revenue by 73.8% annually, reaching 12.05 M TWD. For DuoGenic StemCells, the net margin of -510.9% is up versus -956.9% a few years ago.

DuoGenic StemCells stock price

Access this data via the Eulerpool API

DuoGenic StemCells business model & stock analysis

Duogenic Stemcells Corp. engages in the provision of biotechnology and medical care services. The company is headquartered in Taichung, Taichung. The company went IPO on 2023-05-25. The firm's products include cell separator sets and culture media. The firm also provides various customized cell testing services, product certification and technical consulting services on a consignment basis.

Frequently asked questions about DuoGenic StemCells

Converted at the current exchange rate, the DuoGenic StemCells share trades at 0.24 EUR (8.43 TWD).

The revenue cannot currently be calculated for DuoGenic StemCells.

The profit cannot currently be calculated for DuoGenic StemCells.

The P/E ratio cannot be calculated for DuoGenic StemCells at the moment.

The P/S cannot be calculated for DuoGenic StemCells currently.

The Eulerpool Quality Score for DuoGenic StemCells is 3/10.

The ISIN of DuoGenic StemCells is TW0007607004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of DuoGenic StemCells is 7607.TWO. The ticker symbol is used to trade DuoGenic StemCells shares on the stock exchange.

Fair ValueTerminal
7.42 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website dgsc.com.tw
Country
Taiwan
Currency
TWD
Initial public offering
May 25, 2023
ISIN
TW0007607004
Cusip
Y2R1NC106
Market capitalization
257.54 M TWDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
15.29
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-116.96 %
Last updated Oct 11, 2026, 7:18 AM

DuoGenic StemCells Peer Group

DuoGenic StemCells FIGI

7607:TT (Taipei Stock Exchange) · BBG012DRSSF2